Stéphane Bancel

Stéphane Bancel is Chief Executive Officer & Director at ModernaTX, Inc., Chief Executive Officer & Director at Moderna, Inc. since 2011, Chief Executive Officer at Moderna SpA, Non-Executive Director at Generate Biomedicines, Inc. since 2019, Director at Indigo Ag, Inc. since 2020, Special Partner at Flagship Pioneering, Inc. since 2013, Member-Supervisory Board at QIAGEN GmbH, Trustee at Museum of Science, and Member-Supervisory Board at QIAGEN Srl.
Former roles include Chief Executive Officer at bioMérieux SA from 2007 to 2011, Chief Executive Officer at Moderna Holding BV, Chairman at BG Medicine, Inc. from 2013 to 2015, Executive Director-Global Manufacturing Strategy at Eli Lilly & Co. from 2000 to 2006, Director at Biotheranostics, Inc., Director at Targanta Therapeutics Corp.
from 2008 to 2009, Director at Tafkak, Inc., Managing Director at Eli Lilly Benelux SA, Independent Director at Syros Pharmaceuticals, Inc. from 2013 to 2017, Independent Member-Supervisory Board at QIAGEN NV from 2013 to 2021, and Principal at Eli Lilly & Co. Ltd. Education includes graduate degrees from the University of Minnesota and École Centrale Paris in 1995, and an MBA from Harvard Business School in 2000.